Patents by Inventor Peter Rottgen

Peter Rottgen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof
    Publication number: 20070041977
    Abstract: Single-chain antibodies are described which specifically recognize both the 37 kDa precursor form of the laminin receptor (37 kDa LRP) and the 67 kDa high-affinity form of the laminin receptor (67 kDa LR), and pharmaceutical and diagnostic compositions which contain these single-chain antibodies.
    Type: Application
    Filed: October 8, 2004
    Publication date: February 22, 2007
    Inventors: Stefan Knackmuss, Clemence Rey, Peter Rottgen, Claudia Buttner, Uwe Reusch
  • Generation of diversity in combinatorial libraries
    Publication number: 20050085633
    Abstract: The invention concerns gene banks and combinatorial derivatives thereof, prepared using phagemid- or phage-display in combination with type IIS restriction enzymes and cosmid packaging; their use for the isolation of ligands, including enzyme inhibitors, agonists and antagonists for receptors, competitive binding peptides to a defined target, diagnostic ligands for diseases and autoimmune syndromes, including surveillance tools for immune status, post-translationally modified peptides, and such ligands generated by this technology.
    Type: Application
    Filed: August 13, 2003
    Publication date: April 21, 2005
    Applicant: COSMIX MOLECULAR BIOLOGICALS GMBH
    Inventors: John Collins, Peter Rottgen
  • Generation of diversity in combinatorial libraries
    Publication number: 20020072594
    Abstract: The invention concerns gene banks and combinatorial derivatives thereof, prepared using phagemid- or phage-display in combination with type IIS restriction enzymes and cosmid packaging; their use for the isolation of ligands, including enzyme inhibitors, agonists and antagonists for receptors, competitive binding peptides to a defined target, diagnostic ligands for diseases and autoimmune syndromes, including surveillance tools for immune status, post-translationally modified peptides, and such ligands generated by this technology.
    Type: Application
    Filed: July 24, 2001
    Publication date: June 13, 2002
    Applicant: Cosmix Molecular Biologicals GmbH
    Inventors: John Collins, Peter Rottgen